Oracle Investment Management Inc. In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 19, 2025), Oracle Investment Management Inc. reported 16 stock positions worth $143.3 million . Its top holding was Genedx (WGS) at 66.9% of the portfolio, followed by Biohaven (BHVN, 7.8% ) and Ardelyx (ARDX, 5.8% ). Compared with Q2 2025, it opened 7 new positions, added to 3 and reduced 2. The biggest buy was a new position in Centene (CNC) and the biggest sale Genedx (WGS, shares −4% ).
Location GREENWICH, CT
CIK 0001012622
Portfolio Value $143.3M (Q3 2025) Holdings 16 stocks · $143.3M Holdings quarter Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q2 2025 WGS Genedx Holdings Corp. 889,954 $95.9M Reduce -3.5% BHVN Biohaven Ltd. 739,986 $11.1M Add +9.9% ARDX Ardelyx Inc. 1,503,826 $8.3M Add +5.1% TDOC Teladoc Health Inc. 705,416 $5.5M Add +85.2% PLTR Palantir Technologies Inc. Class A 29,500 $5.4M No change CNC Centene Corp. 110,300 $3.9M New QDEL Quidelortho Corp. 118,291 $3.5M No change FORA Forian Inc. 1,366,107 $3.1M No change NVAX Novavax Inc. 243,000 $2.1M New PSNL Personalis Inc. 229,435 $1.5M New CAVA Cava Group Inc. 17,100 $1.0M Reduce -8.1% KOID Kraneshares Global Humanoid 22,400 $719K New SGMOQ Sangamo Therapeutics Inc. 1,004,724 $677K New BIIB Biogen Inc. 2,412 $338K No change TSLA Tesla Inc. 500 $222K New BDSX Biodesix Inc. 15,000 $113K New
Options reported separately and not counted above: NOVAVAX INC calls ($5.5M), BIOHAVEN LTD calls ($4.1M), TELADOC HEALTH INC calls ($3.6M), ARDELYX INC calls ($3.5M).
Portfolio Sells Q2 2025 → Q3 2025 Portfolio Sells quarter Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q2 2025 % Of Portfolio Change To Portfolio ▲ WGS Genedx Holdings Corp. Reduce -3.5% 66.91% −6.78 CAVA Cava Group Inc. Reduce -8.1% 0.72% −0.64
Portfolio Buys Q2 2025 → Q3 2025 Portfolio Buys quarter Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q2 2025 % Of Portfolio Change To Portfolio ▼ CNC Centene Corp. New 2.75% +2.75 NVAX Novavax Inc. New 1.47% +1.47 PSNL Personalis Inc. New 1.04% +1.04 TDOC Teladoc Health Inc. Add +85.2% 3.81% +0.93 ARDX Ardelyx Inc. Add +5.1% 5.78% +0.93 KOID Kraneshares Global Humanoid New 0.50% +0.50 SGMOQ Sangamo Therapeutics Inc. New 0.47% +0.47 TSLA Tesla Inc. New 0.16% +0.16 BDSX Biodesix Inc. New 0.08% +0.08 BHVN Biohaven Ltd. Add +9.9% 7.75% −0.47
Options Activity Q2 2025 → Q3 2025 Security Type Change vs Q2 2025 Underlying Shares Value ▼ GENEDX HOLDINGS CORP call Sold out 100,000 $9.2Mbefore exit SPRINGWORKS THERAPEUTICS INC call Sold out 150,000 $7.0Mbefore exit NOVAVAX INC call New 635,000 $5.5M BIOHAVEN LTD call Add +37.5% 275,000 $4.1M TELADOC HEALTH INC call Reduce -37.3% 470,500 $3.6M ARDELYX INC call Reduce -46.4% 632,800 $3.5M
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q4 2025 17 $152.6M WGS, ARDX, BHVN, QDEL, FORA Q3 2025 16 $143.3M WGS, BHVN, ARDX, TDOC, PLTR Q2 2025 9 $115.6M WGS, BHVN, ARDX, PLTR, QDEL Q1 2025 11 $153.6M WGS, SWTX, BHVN, ARDX, TDOC Q4 2024 13 $148.9M WGS, BHVN, ARDX, SWTX, QDEL Q3 2024 15 $125.1M WGS, BHVN, PHAT, ARDX, QDEL Q2 2024 16 $93.2M WGS, BHVN, ARDX, SWTX, QDEL Q1 2024 18 $124.2M BHVN, SWTX, ARDX, WGS, EYPT